1 year return (CAGR)
133.64%
Sagimet Biosciences Inc. Series A Common Stock Exchange (NASDAQ, USD)
SGMT
10.46
-0.74 (-8.83%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
467.45M
Price/Sales
-
Ent value
437.53M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.33 |
| Daily high | 8.33 |
| Daily low | 7.61 |
| Daily Volume | 1.02M |
| All-time high | 18.42 |
| 1y analyst estimate | 28.60 |
| Beta | 3.49 |
| EPS (TTM) | -0.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SGMT | S&P500 | |
| Current price drop from All-time high | -43.21% | -3.06% |
| Highest price drop | -89.69% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -65.98% | -10.68% |
| Avg time to new high | 101 days | 12 days |
| Max time to new high | 576 days | 1805 days |
News
